1, 4-dihydropyridines: A class of pharmacologically important molecules

Mini-Reviews in Medicinal Chemistry

Volumn 14, Issue 3, 2014, Pages 282-290

  Khedkar, Samrat A ^a   Auti, Pratibha B ^b  

^a SPM's College of Pharmacy   (India)

^b Sinhgad Institute of Pharmacy   (India)

Author keywords

1,4 dihydropyridine; Antihypertensive; Biological and pharmacological action; Calcium channel modulating agents; Cardiovascular disease; Therapeutic application

Indexed keywords

(4 (4 HYDROXY 3,5 BIS(MORPHOLIN 4 YLMETHYL)PHENYL) 2,6 DIMETHYL 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLIC ACID DIETHYL ESTER); 1 PHENYL 4 GLYCOSYL DIHYDROPYRIDINE; 1,4 DIHYDRO 2,6 DIMETHYL 4 {4 (3 (PIPERIDINE MORPHOLINE 2 AMINOPYRAZINE 1 AMINO 4 METHLPIPERAZINE) 2 HYDROXYPROPOXYL) PHENYL} PYRIDINE 3 5 CARBAMOYL; 1,4 DIHYDROPYRIDINE; 2,20 {[4 (4 SUBSTITUTEDPHENYL) 2,6 DIMETHYL 1,4 DIHYDROPYRIDINE 3,5 DIYL]DICARBONYL} DIHYDRAZINECARBOTHIOAMIDE; 4 ARYL 1,4 DIHYDROPYRIDINE; 4 IMIDAZO [2,1 B]THIAZOLE 1,4 DIHYDROPYRIDINE; 4 IMIDAZO [2,1 B]THIAZOLES 1,4 DIHYDROPYRIDINE; 4 SUBSTITUTED 2,6 DIMETHYL 3,5 BIS N (HETEROARYL) CARBAMOYL 1,4 DIHYDROPYRIDINE; 4 SUBSTITUTED IMIDAZOLYL 2,6 DIMETHYL N3,N5 BISARYL 1,4DIHYDROPYRIDINE 3,5 DICARBOXAMIDE; 7 [2 (DIETHYLAMINO)ETHOXY] 2H CHROMEN 2 ONE; AMLODIPINE; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ANTILEISHMANIAL AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FELODIPINE; GENISTEIN; MULTIDRUG RESISTANCE PROTEIN; N [2 (DIMETHYLAMINO)ETHYL] 3 HYDROXY 2 NAPHTHAMIDE; N,N DIMETHYL N (2 PYRIDIN 3 YL QUINOLIN 4 YL)ETHANE 1,2 DIAMINE; NILVADIPINE; NITRENDIPINE; NITROXYALKYL 1,4 DIHYDROPYRIDINE; SEMICARBAZIDE; THIOSEMICARBAZIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL; VINBLASTINE; DIHYDROPYRIDINE DERIVATIVE;

ALZHEIMER DISEASE; ANTIBACTERIAL ACTIVITY; ANTICOAGULATION; ANTIHYPERTENSIVE ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIULCER ACTIVITY; BIOLOGICAL ACTIVITY; BLOOD PRESSURE; CANCER CHEMOTHERAPY; CARDIOVASCULAR DISEASE; CONTRACEPTION; EPILEPSY; HUMAN; HYPERTENSION; MINIMUM INHIBITORY CONCENTRATION; NEUROPROTECTION; NONHUMAN; REVIEW; RISK FACTOR; DRUG DEVELOPMENT; PROCEDURES;

DIHYDROPYRIDINES; DRUG DISCOVERY; HUMANS;

EID: 84896335251     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557513666131119204126     Document Type: Review

References (47)

1. Saini, A.; Kumar, S.; Shandu, J.S. Hantzsch reaction: Recent advances Hantzsch 1,4 Dihydropyridines. J. Sci. Ind. Res., 2008, 67, 95-111.
2. Meyers, A.; David, M. S.; Recent Advances in the Chemistry of Dihydropyridines. Chem. Rev., 1982, 82, 223-243.
3. Eisner, U.; Kuthan, J. The Chemistry of Dihydropyridines. Chem. Rev., 1972, 72 (1), 1-41.
4. Edward, D.; Frohlich, M.D.; Facc, Achievements in Hypertension: A 25 year Overview. J. Am. Call Cardiol., 1983, 1, 225-239.
5. The fifth report of the Joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med., 1993, 153, 154-183.
6. Guidelines for the Management of Mild Hypertension: Memorandum from a WHOLSH Meeting. Bulletin of the ISH 1993.
7. Testa, R.; Leonardi, A.; Tajana, A.; Riscassi, E.; Magliocca R.; Sartani A., Lercanidipine: A Novel 1,4-Dihydropyridine Calcium Antagonist for Hypertension. Cardiovascular Drug Rev., 1997, 15(3), 187-219.
8. Zhou, K.; Wang, X.; Zhao, Y.; Cao, Y.; Fu, Q.; Zhang S., Synthesis and antihypertensive activity evaluation in spontaneously hypertensive rats of nitrendipine analogs. Med. Chem. Res., 2011, 20, 1325-1330.
9. Mohajeri, S.A.; Hosseinzadeh, H.; Salami, S.; Motamedshariaty, V.; Hadizadeh, M.S., Synthesis of Novel 4-[1-(4-fluorobenzyl)-5- imidazolyl] Dihydropyridines and Studying their Effects on Rat Blood Pressure. Iranian J. Basic Med. Sci., 2011, 14, 451-457.
10. Balaev, A.; Eleev, A.; Eremin, O.; Fedorov, V., Synthesis and antihypertensive activity of 1,4-dihydropyridines containing 3- dialkylamino-2,2-dimethylpropyl fragments. Pharm. Chem. J., 2010, 44, 8-9.
11. Nekooeian, A.A.; Khalili, A.; Javidnia, K.; Mehdipour, A.R.; Miri, R., Antihypertensive effects of some new nitroxyalkyl 1,4 dihydropyridine derivatives in rat model of two-kidney, one-clip hypertension. Iran J. Pharm. Res., 2009, 8 (3), 193-199.
12. Hadizadeh, F.; Fatehi-Hassanabad, M.; Beheshtizadeh, A.; Nabati, F., Synthesis and antihypertensive activity of novel 4-[1-(4-Xbenzyl)- 5-imidazolyl] dihydropyridines in rat. Res. Pharm. Sci., 2007, 2(2), 85-90.
13. Hadizadeh, F.; Fatehi-Hassanabad, Z.; Bamshad, M.; Poorsoghat, H.; Fatehi-Hassanabad M., Synthesis and evaluation of some 1,4 dihydropyridines. Indian J. Chem. B., 2005, 44, 2343-2347.
14. Liang, J.; Yeh, J.; Wang, C.; Liou, S.; Tsai, C.; Chen, I., The New Generation Dihydropyridine Type Calcium Blockers, Bearing 4- Phenyl Oxypropanolamine, Display α-/β-Adrenoceptor Antagonist and Long-Acting Antihypertensive Activities. Bioorg. Med. Chem., 2002, 10, 719-730.
15. Jorjania, M.; Rastegara, H.; Roshanzamir, F.; Varmazyaric, M.; Abdollahi, M.; Zarghi, F., Synthesis and Biological Evaluation of New 1,4-Dihydropyridines as Antihypertensives Agents in Rats. Iran. J. Pharm. Res., 2003, 43-46.
16. Arentz, M.; Hawn, T.R., Tuberculosis Infection: Insight from Immunogenomics. Drug Dis. Today Dis. Mech. 2007, 4(4), 231-236.
17. Janin, Y. L., Antituberculosis drugs: ten years of research. Bioorg. Med. Chem. 2007, 15, 2479-2499.
18. Fassihi, A.; Azadpour, Z.; Delbari, N.; Saghaie, L.; Hamid, R.; Memarian; Sabet, R.; Alborzi, A.; Miri, R.; Pourabbas, B.; Mardaneh, J.; Mousavi, P.; Moeinifard, B.; Sadeghi-aliabadi, H., Synthesis and antitubercular activity of novel 4-substituted imidazolyl-2,6-dimethyl-N3,N5-bisaryl-1,4-dihydropyridine-3,5- dicarboxamides. Eur. J. Med. Chem., 2009, 44, 3253-3258.
19. Khoshneviszadeh, M.; Edraki, N.; Javidnia, K.; Alborzi, A.; Pourabbas, B.; Mardaneh, J.; Miri, R., Synthesis and biological evaluation of some new 1,4-dihydropyridines containing different ester substitute and diethyl carbamoyl groupas anti-tubercular agents. Bioorg. Med. Chem., 2009, 17, 1579-1586.
20. Vijesha, A. M.; Isloorb, A.M.; Peethambarc, S.K.; Shivanandad, K.N.; Arulmolia, T.; Isloore, N.A., Hantzsch reaction: Synthesis and characterization of some new 1,4-dihydropyridine derivatives as potent antimicrobial and antioxidant agents. European J. Med. Chem., 2011, 46, 5591-5597.
21. Aanandhi, V.M.; Kalvikkarasi, S.; Navamani, K.A.; Shanmugasundaram, P. Synthesis, characterization and In-vitro antioxidant activity of Mannich bases of novel 1,4-dihydro pyridines derivatives. RJPBCS, 2010, 1(4), 926-931.
22. Pedemonte, N.; Diena, T.; Caci, E.; Nieddu, E.; Mazzei, M.; Ravazzolo, R.; Zegarra-Moran, O.; Galietta J.V., Antihypertensive 1,4-Dihydropyridines as Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator Channel Gating Defect Caused by Cystic Fibrosis Mutations. Mol. Pharmacol., 2005, 68, 1736-1742.
23. Budriesi, R.; Ioan, P.; Leoni, A.; Pedemonte, N.; Locatelli, A.; Micucci, M.; Chiarini, A.; Galietta, J.V. Cystic Fibrosis: A New Target for 4-Imidazo[2,1-b]thiazole-1, 4-Dihydropyridines. J. Med. Chem., 2011, 54, 3885-3894.
24. Cateni, F.; Zacchigna, M.; Pedemonte, N.; Galietta, J. V.; Mazzei, M.T.; Fossa P.; Giampieri, M.; Mazzei, M. Synthesis of 4- thiophen-20-yl-1,4-dihydropyridines as potentiators of the CFTR chloride channel. Bioorg. Med. Chem., 2009, 17, 7894-7903.
25. Abrego, V.H.; Martinez-Perez, B.; Torres, L. A.; Angeles, E.; Martínez, L.; Marroquín-Pascual, J.L.; Moya-Hernández, R.; Amaro-Recillas, H.A.; Rueda-Jackson, J. C.; Rodríguez-Barrientos, D.; Hernández, A.R. Antihypertensive and antiarrhythmic properties of a para-hydroxy[bis(orthomorpholinylmethyl)] phenyl- 1,4-DHP compound: Comparison with other compounds of the same kind and relationship with logP values. Eur. J. Med. Chem., 2010, 45, 4622-4630.
26. Kiue, A.; Sano, T.; Suzuki, K.; Inada, H.; Okumura, M.; Kikuchi, J.; Sato, S.; Kohno, K.; Kuwano, M. Activities of Newly Synthesized Dihydropyridines in Overcoming of Vincristine Resistance, Calcium Antagonism, and Inhibition of Photoaffinity Labeling of P-Glycoprotein in Rodents. Cancer Res., 1990, 50, 310-317.
27. Surendra, K.; ldhayadhulla, A.; Nasser, J.A.; Murali, K., Synthesis and anticancer activity of some new series of 1,4-dihydropyridines derivatives. Indian J. Chem. B., 2011, 50, 1140-1144.
28. Sirisha, K.; Achaiah, G.; Reddy, V. Facile Synthesis and Antibacterial, Antitubercular, and Anticancer Activities of Novel 1,4-Dihydropyridines. Arch. Pharm. Chem. Life Sci., 2010, 343, 342-352.
29. Zhou, X.; Zhang, L.; Tseng, E.; Scott-Ramsay, E.; Schentag, J.E.; Coburn, R.A.; Morris, M.E. New 4-Aryl-1,4-Dihydropyridines And 4-Arylpyridines As P-Glycoprotein Inhibitors. Drug Metabol. Disposition, 2005, 33(3), 321-328.
30. Pattan, S.R.; Dighe, N.S.; Musmade, D.S.; Tambe, S.K.; Kale, S.H.; Gaware, V.M.; Chavan P. A. Synthesis and evaluation of some new substituted 1,4-dihydro pyridine derivatives and their anticonvulsant activity. J. Chem. Pharm. Res., 2010, 2(1), 246-252.
31. Samzadeh-Kermani, A.; Shafaroodi, H.; Miri, R.; Mirkhani, H.; Vosooghi, M.; Shafiee, A. Lipophilic 2-(4-chlorophenyl)-4- thiazolyl-1,4-dihydropyridines: synthesis, calcium channel antagonist activity, and protection against pentylenetetrazoleinduced seizure. Med. Chem. Res., 2009, 18,112-126.
32. Pathan, S.R.; Purohit, S.S.; Mallya, S.; Marihas, S.C.; Khade, A.B.; Paschpur, M.S. Synthesis and pharmacological of some 1,4- dihydropyridines and their derivatives for anticonvulsant activity. Indian J. Chem.B., 2008, 47, 626-629.
33. Tempone, A.G.; Taniwaki, N.N.; Reimao, J.Q. Antileishmanial activity and ultrastructural alterations of Leishmania (L.) chagasi treated with the calcium channel blocker nimodipine. Parasitol. Res., 2009, 105(2), 499-505.
34. Pandey, V.P.; Bisht, S.S.; Mishra, M.M.; Kumar A.A.; Siddiqi, M.I.; Verma, A.; Mittal, M.; Sane, S. A.; Gupta, S.; Tripathi R. P.Synthesis and molecular docking studies of 1-phenyl-4-glycosyl- Dihydropyridines as potent antileishmanial agents. Eur. J. Med. Chem., 2010, 45, 2381-238.
35. Hjemdahl, P.; Wallen, N.H. Calcium antagonist treatment, sympathetic activity and platelet function. Eu. Heart J., 1997, 18 (Supplement A), A36-A50.
36. Surendra Kumar, R.; Idhayadhulla, A.; Nasser, J.A.; Selvin, J. Synthesis and anticoagulant activity of a new series of 1,4- dihydropyridine Derivatives. Eur. J. Med. Chem., 2011, 46, 804-810.
37. Budriesi, R.; Ioan, P.; Locatelli, A.; Cosconati, S.; Leoni, S.; Ugenti, M.P.; Andreani, A.; Toro, R.D.; Bedini, A.; Spampinato, S.; Marinelli, L.; Novellino, E.; Chiarini, A. Imidazo[2,1-b]thiazole System: A Scaffold Endowing Dihydropyridines with Selective Cardiodepressant Activity. J. Med. Chem., 2008, 51, 1592-1600.
38. Carosati, E.; Budriesi, R.; Ioan, P.; Ugenti, M. P.; Frosini, M.; Fusi, F.; Corda, G.; Cosimelli, B.; Spinelli, D.; Chiarini, A.; Cruciani, G. Discovery of Novel and Cardioselective Diltiazem-like Calcium Channel Blockers via Virtual Screening. J. Med. Chem., 2008, 51, 5552-5565.
39. Arhancet, G.B.; Woodard, S.S; Dietz, J. D.; Garland, D.J.; Wagner, G.M.; Iyanar, K.; Collins, J.T.; Blinn, J.R.; Numann, R.E.; Hu, X.; Huang, H. Stereochemical Requirements for the Mineral corticoid Receptor Antagonist Activity of Dihydropyridines. J. Med. Chem., 2010, 53, 4300-4304.
40. Arhancet, G.B.; Woodard, S.S.; Iyanar, K.; Case, B.L.; Woerndle, R.; Dietz, J.D.; Garland, D.J.; Collins, J.T.; Payne, M.A.; Blinn, J.R.; Pomposiello, S. I.; Hu, X.; Heron, M. I.; Huang, H., Lee, L.F. Discovery of Novel Cyanodihydropyridines as Potent Mineral corticoid Receptor Antagonists. J. Med. Chem., 2010, 53, 5970-5978.
41. Subhudhi, B.B.; Panda, P.K.; Bhatta, D. Synthesis And Antiulcer Study of 1,4 Dihydropyridines And Their Mannich Bases With Sulphanilamide. Indian J. Chem. B., 2009, 48, 725-728.
42. Goedert, M.; Spillantini, M. G. A century of Alzheimer's disease. Science, 2006, 314, 777-781.
43. León, R.; Rios, C. L.; Marco-Contelles, J.; Huertas, O.; Barril, X.; Luque, F.J.; Lopez, M.G.; Garcia, A.G.; Villarroya, M. New tacrine-dihydropyridine hybrids that inhibit acetylcholinesterase, calcium entry, and exhibit neuroprotection propertie. Bioorg. Med. Chem., 2008, 16, 7759-7769.
44. Contelles, J.M.; Leon, R.; Rios, C.L.; Samadi, A.L.; Bartolini, M.; Andrisano, V.; Huertas, O.; Barril, X.; Luque, F.J.; Guez-Franco, M.R.; Lopez, B.; Lopez, A.G.; Garcia, A.G.; Carreiras, M.C.; Villarroya, M. Tacripyrines, the First Tacrine-Dihydropyridine Hybrids, as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease. J. Med. Chem., 2009, 52, 2724-2732.
45. Hilgerotha, A.; Billichb, A.; Liliec, H. Synthesis and biological evaluation of first N-alkyl syn dimeric 4-aryl-1,4-dihydropyridines as competitive HIV-1 protease inhibitors. Eur. J. Med. Chem., 2001, 36, 367-374.
46. Hilgeroth, A.; Lilie, H. Structure-activity relationships of first bishydroxymethyl-substituted cage dimeric 4-aryl-1,4-dihydropyridines as HIV-1 protease inhibitors. Eur. J. Med. Chem., 2003, 38, 495-499.
47. Waghmare, A.; Kanyalkar, M.; Joshi, M.; Srivastava, S. In-Vitro Metabolic Inhibition and Antifertility Effect Facilitated By Membrane Alteration: Search for Novel Antifertility Agent Using Nifedipine Analogs. Eur. J. Med. Chem., 2011, 46, 3581-3589.